Cullinan Oncology LLC

Price & Volume

Track all markets on TradingView

Stats

See more
Open
$11.40
Previous Close
$11.37
Day Range
$10.42-$11.45
52W Range
$5.68-$13.62
Market Cap
$671.6M
Shares Short
6M

Financials

See more
Revenue (12 Mos)
$0
Revenue Growth (YoY)
0%
Gross Profit (12 Mos)
$18.9M
Diluted EPS
-$3.32

News

See more

Yahoo Finance • 2 hours ago

Cullinan Therapeutics Announces Fast Track Designation For CLN-049

Yahoo Finance • 4 hours ago

Cullinan Therapeutics Receives FDA Fast Track Designation for CLN-049, a Novel FLT3xCD3 T Cell Engager, in Relapsed/Refractory Acute Myeloid Leukemia

Yahoo Finance • 28 days ago

Cullinan Therapeutics to Showcase New Data Demonstrating Compelling Clinical Activity for CLN-049, a Novel FLT3xCD3 T Cell Engager, in AML Patients in an Oral Presentation at the 67th ASH Annual Meeting

Yahoo Finance • last month

Cullinan Therapeutics Shares Additional Preclinical B Cell Depletion Data for CLN-978, Supporting Clinical Development Across Multiple Autoimmune Diseases, at ACR Convergence 2025

About

CEO
Mr. Nadim Ahmed
Address
One Main Street, Cambridge, MA, United States, 02142
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
111